BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Sector: Services-Medical Laboratories
Industry: Industrial - Distribution
BioNexus Gene Lab Corp.
- 0.3%
- 3.2K
- 1.00
Float 1.24M · Signal8 dilution snapshot · Aug 14, 2026
The cost to borrow BGLC shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 88.3%
- 597
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 3.2K sh |
| Oct 15, 2026 | 9.1K sh |
| Sep 30, 2026 | 10.1K sh |
| Sep 15, 2026 | 13.0K sh |
| Aug 31, 2026 | 7.5K sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Sep 24, 2026 | 597 sh |
| Sep 23, 2026 | 37 sh |
| Sep 22, 2026 | 13 sh |
| Sep 21, 2026 | 2.1K sh |
| Sep 10, 2026 | 675 sh |
A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Latest sessions
| Date | Reported short |
|---|---|
| Nov 16, 2026 | 88.3% |
| Nov 13, 2026 | 1.1% |
| Nov 12, 2026 | 76.7% |
| Nov 11, 2026 | 76.2% |
| Nov 10, 2026 | 15.3% |
130 calendar days requested; 90 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.
Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
FINRA's weekly alternative trading system (dark pool) volume for BGLC: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 3,180 BGLC shares were sold short (0.26% of a 1.24M-share float, 1.00 days to cover).